Lantheus Holdings, Inc. - Common Stock (NQ:LNTH)

81.43 +1.40 (+1.75%)

Streaming Delayed Price Updated: 4:00 PM EDT, Apr 9, 2026 Add to My Watchlist

Price and Volume

Volume	693,158
Open	79.53
Bid (Size)	80.00 (100)
Ask (Size)	83.00 (400)
Prev. Close	80.03
Today's Range	79.14 - 82.44
52wk Range	47.25 - 108.91
Shares Outstanding	67,604,097
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

3 Profitable Stocks We Think Twice About

Today 0:35 EDT

Even if a company is profitable, it doesn’t always mean it’s a great investment. Some struggle to maintain growth, face looming threats, or fail to reinvest ...

Via StockStory

3 Cash-Producing Stocks Walking a Fine Line

April 08, 2026

Generating cash is essential for any business, but not all cash-rich companies are great investments. Some produce plenty of cash but fail to allocate it eff...

Via StockStory

Performance

YTD	+21.0%	+21.0%
1 Month	+1.8%	+1.8%
3 Month	+17.4%	+17.4%
6 Month	+52.1%	+52.1%
1 Year	-12.8%	-12.8%

More News

1 of Wall Street’s Favorite Stock for Long-Term Investors and 2 We Ignore

April 07, 2026

Via StockStory

3 Russell 2000 Stocks We’re Skeptical Of

March 25, 2026

Via StockStory

Lantheus Holdings Inc (NASDAQ:LNTH) Beats Q4 Estimates but 2026 Guidance Disappoints ↗

February 26, 2026

Via Chartmill

Lantheus Holdings Inc. (NASDAQ:LNTH) Presents a Compelling Value Investment Case ↗

February 20, 2026

Via Chartmill

Lantheus Says FDA Pushed Deadline For Reviewing Its Tumor Diagnostic Kit Application ↗

March 17, 2026

Via Stocktwits

Lantheus Announces Three-Month Extension of PDUFA Date for LNTH-2501 (Ga 68 edotreotide), a PET Diagnostic Imaging Kit Targeting Somatostatin Receptor-Positive (SSTR+) Neuroendocrine Tumors (NETs)

March 17, 2026

From Lantheus Holdings, Inc.

Via GlobeNewswire

3 Reasons to Sell LNTH and 1 Stock to Buy Instead

March 12, 2026

Via StockStory

Q4 Earnings Highlights: Lantheus (NASDAQ:LNTH) Vs The Rest Of The Medical Devices & Supplies - Imaging, Diagnostics Stocks

March 10, 2026

Via StockStory

Why Lantheus Holdings Stock Popped by Almost 12% Last Month ↗

March 09, 2026

Via The Motley Fool

Why Is LNTH Stock Up After Hours? ↗

March 06, 2026

Via Stocktwits

Lantheus Announces FDA Approval of PYLARIFY TruVu™ (piflufolastat F 18) Injection

March 06, 2026

From Lantheus Holdings, Inc.

Via GlobeNewswire

Lantheus Holdings Investigation Initiated: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Lantheus Holdings, Inc. - LNTH

March 02, 2026

From Kahn Swick & Foti, LLC

Via Business Wire

Lantheus Receives FDA Tentative Approval for Lutetium Lu 177 Dotatate (PNT2003), Radioequivalent to LUTATHERA®

March 02, 2026

From Lantheus Holdings, Inc.

Via GlobeNewswire

Lantheus (LNTH) Q4 2025 Earnings Call Transcript ↗

February 26, 2026

Via The Motley Fool

Lantheus (NASDAQ:LNTH) Exceeds Q4 CY2025 Expectations

February 26, 2026

Via StockStory

Lantheus Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update

February 26, 2026

From Lantheus Holdings, Inc.

Via GlobeNewswire

Lantheus Earnings: What To Look For From LNTH

February 24, 2026

Via StockStory

Lantheus to Present at March 2026 Investor Conferences

February 24, 2026

From Lantheus Holdings, Inc.

Via GlobeNewswire

2 Value Stocks to Target This Week and 1 Facing Headwinds

February 17, 2026

Via StockStory

Lantheus to Host Fourth Quarter and Full Year 2025 Earnings Conference Call and Webcast on February 26, 2026, at 8:00 a.m. Eastern Time

February 12, 2026

From Lantheus Holdings, Inc.

Via GlobeNewswire

2 Small-Cap Stocks Worth Investigating and 1 We Avoid

February 03, 2026

Via StockStory

Lantheus Holdings Investigation Initiated: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Lantheus Holdings, Inc. - LNTH

January 31, 2026

From Kahn Swick & Foti, LLC

Via Business Wire

3 Market-Beating Stocks for Long-Term Investors

January 11, 2026

Via StockStory

Frequently Asked Questions

Is Lantheus Holdings, Inc. - Common Stock publicly traded?

Yes, Lantheus Holdings, Inc. - Common Stock is publicly traded.

What exchange does Lantheus Holdings, Inc. - Common Stock trade on?

Lantheus Holdings, Inc. - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for Lantheus Holdings, Inc. - Common Stock?

The ticker symbol for Lantheus Holdings, Inc. - Common Stock is LNTH on the Nasdaq Stock Market

What is the current price of Lantheus Holdings, Inc. - Common Stock?

The current price of Lantheus Holdings, Inc. - Common Stock is 81.43

When was Lantheus Holdings, Inc. - Common Stock last traded?

The last trade of Lantheus Holdings, Inc. - Common Stock was at 04/09/26 04:00 PM ET

What is the market capitalization of Lantheus Holdings, Inc. - Common Stock?

The market capitalization of Lantheus Holdings, Inc. - Common Stock is 5.51B

How many shares of Lantheus Holdings, Inc. - Common Stock are outstanding?

Lantheus Holdings, Inc. - Common Stock has 6B shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.